Starting Dose of Lexapro for 16-Year-Old Female
The starting dose of escitalopram (Lexapro) for a 16-year-old female is 10 mg once daily, taken orally in the morning or evening, with or without food. 1
Dosing Specifics
The FDA-approved labeling is clear and unequivocal for this age group:
- Starting dose: 10 mg once daily for pediatric patients 12 years of age and older with major depressive disorder 1
- Maximum dose: 20 mg once daily, which can be increased at intervals of no less than 3 weeks if needed based on clinical response and tolerability 1
- Administration can be morning or evening, with or without food 1
This recommendation is reinforced by the GLAD-PC guidelines, which list escitalopram with a starting dose of 10 mg, increments of 5 mg, an effective dose of 10 mg, and maximum of 20 mg 2. Notably, escitalopram is the only SSRI (besides fluoxetine) with FDA approval for adolescents aged 12 years and older 2.
Critical Safety Considerations
Before prescribing, you must screen for personal or family history of bipolar disorder, mania, or hypomania 1. This is essential because:
- Starting at higher doses increases the risk of behavioral activation, mania switching, and suicide-related events 2
- Case reports demonstrate dose-related treatment-emergent mania/hypomania with escitalopram, particularly when increased to 20 mg/day 3
Close monitoring is mandatory, especially during:
- The initial few months of treatment
- Any dose changes (increases or decreases)
- Contact (in-person or telephone) should occur after initiation to review adherence, current status, and emergence of adverse events 2, 1
Common Pitfalls to Avoid
- Do NOT start at higher doses - This significantly increases risk of deliberate self-harm and suicide-related events 2
- Do NOT rush dose escalation - Wait at least 3 weeks before increasing to 20 mg in adolescents (longer than the 1-week interval used in adults) 1
- Do NOT abruptly discontinue - Always taper gradually to avoid withdrawal effects 2, 1
- Do NOT use with MAOIs - Contraindicated; requires 14-day washout period 2, 1
Expected Outcomes
Research demonstrates that 10-20 mg daily dosing in adolescents results in clinically meaningful improvement, with remission rates of approximately 50% at 24 weeks 4. The most common adverse events are mild to moderate: headache, nausea, insomnia, vomiting, and influenza-like symptoms 4.